DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/aa0f7f/acute_coronary_syn) has announced the addition of GlobalData's new report "Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017" to their offering.
Acute Coronary Syndrome - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global ACS market. The report identifies the key trends shaping and driving the global ACS market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global ACS sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
The global Acute Coronary Syndrome (ACS) market was valued at $1.8 billion in 2009 and is forecast to grow by 2.9% annually for the next seven years to reach $2.25 billion in 2017. This growth in market size is primarily due to the launch of promising molecules which are in Phase III trials and the filing of Brilinta, which has been recommended by the US FDA (Food and Drug Administration) advisory committee to the US FDA for the approval. From 2009 to 2017 there will be patent expirations for five branded drugs, which will subsequently allow the entry of generics into the market and the new molecules may face competition from these generics. Although the patent expires of the branded drugs are expected to negatively impact the market growth, the entry of filed drug Brilinta, the anticipated entry of Vorapaxar, varespladib methyl (A-002), Otamixaban, Xarelto and Darapladib 160mg would diminish the negative impact.
Key Topics Covered:
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Global Acute coronary syndrome (ACS) Market: Introduction
- 3 Global Acute Coronary Syndrome: Market Characterization
- 4 Global Acute Coronary Syndrome Market: Competitive Assessment
- 5 Global Acute Coronary Syndome Market: Pipeline Assessment
- 6 Global Acute Coronary Syndrome Market: Implications for Future Market Competition
- 7 Global Acute Coronary Syndrome Therapeutics Market: Future Players
- 8 Acute Coronary Syndrome Market: Appendix
For more information visit http://www.researchandmarkets.com/research/aa0f7f/acute_coronary_syn.